SMTL ID : 5tvj.1

Crystal structure of acetyltransferase Eis from Mycobacterium tuberculosis in complex with CoA and inhibitor 2k*: 1-(4-fluorophenyl)-2-[2-(4-methylphenyl)-2-oxoethyl]pyrrolo[1,2-a]pyrazin-2-ium

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

homo-hexamer

Ligands

6 x COA: COENZYME A(Non-covalent)

COA.1: 16 residues within 4Å: Chain A: V.105, V.107, R.112, R.113, R.114, G.115, L.116, L.117, R.118, H.139, E.142, I.145, Y.146, R.148 Chain C: D.280 Ligands: 7LF.2 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:V.107, A:L.117 Hydrogen bonds: A:R.113, A:R.113, A:G.115, A:G.115, A:L.116, A:L.117, A:R.118, A:E.142, A:Y.146, A:R.148 Water bridges: A:R.114, A:R.114 COA.5: 16 residues within 4Å: Chain A: D.280 Chain B: V.105, V.107, R.112, R.113, R.114, G.115, L.116, L.117, R.118, H.139, E.142, I.145, Y.146, R.148 Ligands: 7LF.6 14 PLIP interactions: 14 interactions with chain B Hydrophobic interactions: B:V.107, B:L.117 Hydrogen bonds: B:R.113, B:R.113, B:G.115, B:G.115, B:L.116, B:L.117, B:R.118, B:E.142, B:Y.146, B:R.148 Water bridges: B:R.114, B:R.114 COA.9: 16 residues within 4Å: Chain B: D.280 Chain C: V.105, V.107, R.112, R.113, R.114, G.115, L.116, L.117, R.118, H.139, E.142, I.145, Y.146, R.148 Ligands: 7LF.10 14 PLIP interactions: 14 interactions with chain C Hydrophobic interactions: C:V.107, C:L.117 Hydrogen bonds: C:R.113, C:R.113, C:G.115, C:G.115, C:L.116, C:L.117, C:R.118, C:E.142, C:Y.146, C:R.148 Water bridges: C:R.114, C:R.114 COA.13: 16 residues within 4Å: Chain D: V.105, V.107, R.112, R.113, R.114, G.115, L.116, L.117, R.118, H.139, E.142, I.145, Y.146, R.148 Chain F: D.280 Ligands: 7LF.14 13 PLIP interactions: 13 interactions with chain D Hydrophobic interactions: D:V.107, D:L.117 Hydrogen bonds: D:R.113, D:R.113, D:G.115, D:G.115, D:L.116, D:L.117, D:R.118, D:E.142, D:R.148 Water bridges: D:R.114, D:R.114 COA.17: 16 residues within 4Å: Chain D: D.280 Chain E: V.105, V.107, R.112, R.113, R.114, G.115, L.116, L.117, R.118, H.139, E.142, I.145, Y.146, R.148 Ligands: 7LF.18 13 PLIP interactions: 13 interactions with chain E Hydrophobic interactions: E:V.107, E:L.117 Hydrogen bonds: E:R.113, E:R.113, E:G.115, E:G.115, E:L.116, E:L.117, E:R.118, E:E.142, E:R.148 Water bridges: E:R.114, E:R.114 COA.21: 16 residues within 4Å: Chain E: D.280 Chain F: V.105, V.107, R.112, R.113, R.114, G.115, L.116, L.117, R.118, H.139, E.142, I.145, Y.146, R.148 Ligands: 7LF.22 13 PLIP interactions: 13 interactions with chain F Hydrophobic interactions: F:V.107, F:L.117 Hydrogen bonds: F:R.113, F:R.113, F:G.115, F:G.115, F:L.116, F:L.117, F:R.118, F:E.142, F:R.148 Water bridges: F:R.114, F:R.114

6 x 7LF: 1-(4-fluorophenyl)-2-[2-(4-methylphenyl)-2-oxoethyl]pyrrolo[1,2-a]pyrazin-2-ium(Non-covalent)

7LF.2: 14 residues within 4Å: Chain A: W.33, F.44, D.46, I.48, A.53, W.56, R.57, L.83, S.103, F.104, V.105, E.421, F.422 Ligands: COA.1 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:W.33, A:A.53, A:W.56, A:R.57, A:L.83 pi-Stacking: A:F.44, A:F.104 7LF.6: 14 residues within 4Å: Chain B: W.33, F.44, D.46, I.48, A.53, W.56, R.57, L.83, S.103, F.104, V.105, E.421, F.422 Ligands: COA.5 7 PLIP interactions: 7 interactions with chain B Hydrophobic interactions: B:W.33, B:A.53, B:W.56, B:R.57, B:L.83 pi-Stacking: B:F.44, B:F.104 7LF.10: 14 residues within 4Å: Chain C: W.33, F.44, D.46, I.48, A.53, W.56, R.57, L.83, S.103, F.104, V.105, E.421, F.422 Ligands: COA.9 7 PLIP interactions: 7 interactions with chain C Hydrophobic interactions: C:W.33, C:A.53, C:W.56, C:R.57, C:L.83 pi-Stacking: C:F.44, C:F.104 7LF.14: 14 residues within 4Å: Chain D: W.33, F.44, D.46, I.48, A.53, W.56, R.57, L.83, S.103, F.104, V.105, E.421, F.422 Ligands: COA.13 7 PLIP interactions: 7 interactions with chain D Hydrophobic interactions: D:W.33, D:A.53, D:W.56, D:R.57, D:L.83 pi-Stacking: D:F.44, D:F.104 7LF.18: 14 residues within 4Å: Chain E: W.33, F.44, D.46, I.48, A.53, W.56, R.57, L.83, S.103, F.104, V.105, E.421, F.422 Ligands: COA.17 7 PLIP interactions: 7 interactions with chain E Hydrophobic interactions: E:W.33, E:A.53, E:W.56, E:R.57, E:L.83 pi-Stacking: E:F.44, E:F.104 7LF.22: 14 residues within 4Å: Chain F: W.33, F.44, D.46, I.48, A.53, W.56, R.57, L.83, S.103, F.104, V.105, E.421, F.422 Ligands: COA.21 7 PLIP interactions: 7 interactions with chain F Hydrophobic interactions: F:W.33, F:A.53, F:W.56, F:R.57, F:L.83 pi-Stacking: F:F.44, F:F.104

6 x GOL: GLYCEROL(Non-functional Binders)

GOL.3: 6 residues within 4Å: Chain A: R.262, I.288, T.289, H.290, Q.417, T.418 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:R.262, A:T.289, A:T.289, A:T.418, A:T.418, A:T.418 GOL.7: 6 residues within 4Å: Chain B: R.262, I.288, T.289, H.290, Q.417, T.418 6 PLIP interactions: 6 interactions with chain B Hydrogen bonds: B:R.262, B:T.289, B:T.289, B:T.418, B:T.418, B:T.418 GOL.11: 6 residues within 4Å: Chain C: R.262, I.288, T.289, H.290, Q.417, T.418 6 PLIP interactions: 6 interactions with chain C Hydrogen bonds: C:R.262, C:T.289, C:T.289, C:T.418, C:T.418, C:T.418 GOL.15: 6 residues within 4Å: Chain D: R.262, I.288, T.289, H.290, Q.417, T.418 4 PLIP interactions: 4 interactions with chain D Hydrogen bonds: D:R.262, D:T.289, D:T.418, D:T.418 GOL.19: 6 residues within 4Å: Chain E: R.262, I.288, T.289, H.290, Q.417, T.418 4 PLIP interactions: 4 interactions with chain E Hydrogen bonds: E:R.262, E:T.289, E:T.418, E:T.418 GOL.23: 6 residues within 4Å: Chain F: R.262, I.288, T.289, H.290, Q.417, T.418 4 PLIP interactions: 4 interactions with chain F Hydrogen bonds: F:R.262, F:T.289, F:T.418, F:T.418

6 x CL: CHLORIDE ION(Non-functional Binders)

CL.4: 7 residues within 4Å: Chain A: R.88, L.89, T.90, V.96, R.203, G.209, L.211 Ligand excluded by PLIP CL.8: 7 residues within 4Å: Chain B: R.88, L.89, T.90, V.96, R.203, G.209, L.211 Ligand excluded by PLIP CL.12: 7 residues within 4Å: Chain C: R.88, L.89, T.90, V.96, R.203, G.209, L.211 Ligand excluded by PLIP CL.16: 7 residues within 4Å: Chain D: R.88, L.89, T.90, V.96, R.203, G.209, L.211 Ligand excluded by PLIP CL.20: 7 residues within 4Å: Chain E: R.88, L.89, T.90, V.96, R.203, G.209, L.211 Ligand excluded by PLIP CL.24: 7 residues within 4Å: Chain F: R.88, L.89, T.90, V.96, R.203, G.209, L.211 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Garzan, A. et al., Combating Enhanced Intracellular Survival (Eis)-Mediated Kanamycin Resistance of Mycobacterium tuberculosis by Novel Pyrrolo[1,5-a]pyrazine-Based Eis Inhibitors. ACS Infect Dis (2017)

Release Date

2017-03-01

Peptides

Enhanced intracellular survival protein: ABCDEF

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

C
A

D
A

E
A

F
A

Enhanced intracellular survival protein

Related Entries With Identical Sequence